 Anika Therapeutics, Inc. NASDAQ: ANIK, a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid HA technology platform, today announced that Cheryl R. Blanchard, Ph.D., has been named President and Chief Executive Officer, effective April 26,2020. Dr. Blanchard has served as interim Chief Executive Officer of Anika since February 2020 and as a member of the Companys Board of Directors since August 2018. Dr. Blanchard has more than 25 years of executive management experience with deep expertise in orthopedic medical devices, regenerative medicine and drug delivery. 